The name Stiefel Laboratories has been associated with innovative product developments as
well as many skin care firsts throughtout our history.
A recent innovation from Stiefel Laboratories represents a major improvement for those who
struggle with inflammatory acne. Duac® Topical Gel - the first and only 1%
clindamycin and 5% benzoyl peroxide combination approved by the FDA for
once-a-day dosing. The dual action of these two ingredients has been proven
more effective for inflammatory acne than either product used alone. It is
also unique in that it does not have to be compounded at the pharmacy,
providing a "ready to dispense" formulation, unlike similiar combination
products. As an extra convenience, it does not have to be refrigerated by the
patient. Duac® Topical Gel is distributed as Clindoxyl® Gel in Argentina,
Brazil, Canada, and the United Kingdom, and as Indoxyl® Gel in Mexico and Peru
Visit http://www.duacgel.com/ for more
information.
MimyX® Cream
MimyX® is developed with innovative ingredients for treating
dry sensitive skin associated with atopic dermatitis. Clinically proven safe,
MimyX® helps restore natural skin lipids. Other available products
"moisturize", MimyX® "repairs" the skin's protective barrier with a
dermatological base cream that is similar to the skin's own lipid structure.
MimyX® is made without emulsifiers or surfactants, is hypoallergenic,
non-irritating, non-sensitising, and steroid free.